Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society

Gynecol Oncol. 2020 May;157(2):303-306. doi: 10.1016/j.ygyno.2020.01.035. Epub 2020 Feb 15.
No abstract available

Publication types

  • Review

MeSH terms

  • Female
  • Genetic Predisposition to Disease
  • Genital Neoplasms, Female / genetics
  • Genital Neoplasms, Female / surgery
  • Genital Neoplasms, Female / therapy*
  • Hormone Replacement Therapy*
  • Humans
  • Menopause, Premature
  • Practice Guidelines as Topic
  • Randomized Controlled Trials as Topic
  • Risk Factors